|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/517 | (2006.01) |
| A61K 31/517 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3846819 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19742015.1 |
| Date of filing the European patent application | 2019-07-15 | |
| (97) | Date of publication of the European application | 2021-07-14 |
| (45) | Date of publication and mention of the grant of the patent | 2024-01-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2019/069039 |
| Date | 2019-07-15 |
| (87) | Number | WO 2020/016191 |
| Date | 2020-01-23 |
| (30) | Number | Date | Country code |
| 18382527 | 2018-07-16 | EP |
| (72) |
SURRALLÉS CALONGE, Jordi , ES
MINGUILLÓN PEDREÑO, Jordi , ES
MONTANUY ESCRIBANO, Helena , ES
|
| (73) |
Universitat Autònoma de Barcelona ,
Oficina de Valorització i Patents Edifici A.
Rectorat - Campus universitari s/n, 08193 Bellaterra,
ES
Consorcio Centro de Investigación Biomédica en Red M.P. , C/Monforte de Lemos 3-5 Pabellón 11, 28029 Madrid, ES Fundacio Institut de Recerca de l'Hospital de la Santa Creu i sant Pau , C. Sant Antoni Maria Claret, 167, 08025 Barcelona, ES |
| (54) | THERAPEUTIC USE OF AFATINIB IN CANCER |
| THERAPEUTIC USE OF AFATINIB IN CANCER |